Phase II study of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) in the treatment of bronchogenic carcinoma. [electronic resource]
Producer: 19720915Description: 259-61 p. digitalISSN:- 0069-0112
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.